KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 14.13
+0.06 (0.43%)
Sep 5, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Pharmaceutical | 4.45B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Wholesale | 3.95B | Log In | Log In | Log In | Log In | Upgrade |
Wholesale and Retail of Medicines and Equipment | - | Log In | Log In | Log In | Log In | Upgrade |
Wholesale and Retail of Medicines and Equipment Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Treatment Areas | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Treatment Areas Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Digestive System | - | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Gynecology | - | Log In | Log In | Log In | Log In | Upgrade |
Gynecology Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Orthopedics Series | - | Log In | Log In | Log In | Log In | Upgrade |
Orthopedics Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-malaria | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-malaria Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Commodity | - | Log In | Log In | Log In | Log In | Upgrade |
Commodity Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Services | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-infection | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-infection Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Liver Qi Stagnation | - | Log In | Log In | Log In | Log In | Upgrade |
Liver Qi Stagnation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Health Food Production | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 8.26B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 9.01% | Log In | Log In | Log In | Log In | Upgrade |
Abroad | 140.14M | Log In | Log In | Log In | Log In | Upgrade |
Abroad Growth | 20.02% | Log In | Log In | Log In | Log In | Upgrade |
Hong Kong | 949.76K | Log In | Log In | Log In | Log In | Upgrade |
Hong Kong Growth | -90.01% | Log In | Log In | Log In | Log In | Upgrade |